United States Financial Markets News
Sign up for free!
Get instant access to all of our market news and analysis with our free REST API.
Search entities
Discover all 32,649 supported financial entities for United States financial markets here.
Latest news
Live response for past 24 hours
{
"meta": {
"found": 2676,
"returned": 10,
"limit": 10,
"page": 1
},
"data": [
{
"uuid": "0b139a38-baff-4e4d-ab42-0d395624f3f9",
"title": "Zymeworks Announces NMPA Approval of Zanidatamab in China for Adults with Previously Treated, Unresectable or Metastatic HER2-high expression (IHC3+) Biliary Tract Cancer | ZYME Stock News",
"description": "Zymeworks (ZYME) receives NMPA approval in China for zanidatamab, a first-of-its-kind bispecific antibody for HER2+ biliary tract cancer. The approval t",
"keywords": "GuruFocus, Article, News, GuruFocus News, ZYME",
"snippet": "Zymeworks (ZYME, Financial) receives NMPA approval in China for zanidatamab, a first-of-its-kind bispecific antibody for HER2+ biliary tract cancer.\n\nThe approv...",
"url": "https://www.gurufocus.com/news/2897907/zymeworks-announces-nmpa-approval-of-zanidatamab-in-china-for-adults-with-previously-treated-unresectable-or-metastatic-her2high-expression-ihc3-biliary-tract-cancer-zyme-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C0000B8PX.png?20",
"language": "en",
"published_at": "2025-05-30T11:16:34.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "ZYME",
"name": "Zymeworks Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 43.20767,
"sentiment_score": 0.302429,
"highlights": [
{
"highlight": "<em>Zymeworks</em> (ZYME, Financial) rec[+244 characters]",
"sentiment": 0.2023,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Zymeworks</em> <em>Inc</em>. (Nasdaq[+291 characters]",
"sentiment": 0.4215,
"highlighted_in": "main_text"
},
{
"highlight": "., which will result in a $20 million mi[+206 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Zymeworks</em> is also set to receiv[+233 characters]",
"sentiment": 0.7096,
"highlighted_in": "main_text"
},
{
"highlight": "This development highlights <em>Zymework[+138 characters]",
"sentiment": 0.5574,
"highlighted_in": "main_text"
},
{
"highlight": "The company's global regulatory progress[+160 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Zymeworks</em> Announces NMPA Approval of Zanidatamab in China for Adults with Previously Treated, Unresectable or Metastatic HER2-high expression (IHC3+) Biliary Tract Cancer | ZYME Stock News",
"sentiment": -0.3182,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "812bf3f5-6b82-4d4f-aa7c-3d82b96ec577",
"title": "Zymeworks Announces NMPA Approval of Zanidatamab in China for Adults with Previously Treated, Unresectable or Metastatic HER2-high expression (IHC3+) Biliary Tract Cancer",
"description": "Zanidatamab is the first and only dual HER2-targeted bispecific antibody approved for HER2+ biliary tract cancer in China; conditional approval based on the res",
"keywords": "GuruFocus, Article, News, Marketwired, ZYME",
"snippet": "Zanidatamab is the first and only dual HER2-targeted bispecific antibody approved for HER2+ biliary tract cancer in China; conditional approval based on the res...",
"url": "https://www.gurufocus.com/news/2897849/zymeworks-announces-nmpa-approval-of-zanidatamab-in-china-for-adults-with-previously-treated-unresectable-or-metastatic-her2high-expression-ihc3-biliary-tract-cancer",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-05-30T11:00:02.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "BGNE",
"name": "BeiGene, Ltd.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 22.380703,
"sentiment_score": 0.5672,
"highlights": [
{
"highlight": "(formerly <em>BeiGene</em>, <em>Ltd</em>[+277 characters]",
"sentiment": 0.9081,
"highlighted_in": "main_text"
},
{
"highlight": "(formerly <em>BeiGene</em>, <em>Ltd</em>[+151 characters]",
"sentiment": 0.2263,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "ZYME",
"name": "Zymeworks Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 38.58484,
"sentiment_score": 0.048855,
"highlights": [
{
"highlight": "and commercial milestones\n\nVANCOUVER, Br[+328 characters]",
"sentiment": 0.4588,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Zymeworks</em>’ collaboration part[+181 characters]",
"sentiment": 0.743,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Zymeworks</em> is entitled to receiv[+312 characters]",
"sentiment": 0.6369,
"highlighted_in": "main_text"
},
{
"highlight": "These mechanisms result in tumor growth [+249 characters]",
"sentiment": -0.1779,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Zymeworks</em>’ mission is to make[+143 characters]",
"sentiment": -0.4767,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Zymeworks</em> engineered and develo[+193 characters]",
"sentiment": 0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "In addition to <em>Zymeworks</em>’ pip[+229 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "All forward-looking statements are based[+290 characters]",
"sentiment": -0.4215,
"highlighted_in": "main_text"
},
{
"highlight": "Actual results could differ materially f[+334 characters]",
"sentiment": -0.0453,
"highlighted_in": "main_text"
},
{
"highlight": "’ business, research and clinical deve[+341 characters]",
"sentiment": -0.1349,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Zymeworks</em> Announces NMPA Approval of Zanidatamab in China for Adults with Previously Treated, Unresectable or Metastatic HER2-high expression (IHC3+) Biliary Tract Cancer",
"sentiment": -0.3182,
"highlighted_in": "title"
}
]
},
{
"symbol": "BGNEN.MX",
"name": "BeiGene, Ltd.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "N/A",
"match_score": 22.37984,
"sentiment_score": 0.5672,
"highlights": [
{
"highlight": "(formerly <em>BeiGene</em>, <em>Ltd</em>[+277 characters]",
"sentiment": 0.9081,
"highlighted_in": "main_text"
},
{
"highlight": "(formerly <em>BeiGene</em>, <em>Ltd</em>[+151 characters]",
"sentiment": 0.2263,
"highlighted_in": "main_text"
}
]
}
]
},
{
"uuid": "12a58b6f-b249-4025-b996-ecb1a8c912e7",
"title": "BRP Inc. (DOOO) Receives Upgrade Amid Improving Sales Outlook | DOOO Stock News",
"description": "In a recent analysis, Stifel's Martin Landry upgraded BRP Inc. (DOOO) from a Hold to a Buy, raising the price target from C$45 to C$68. Despite reporting an 8%",
"keywords": "GuruFocus, Article, News, GuruFocus News, DOOO",
"snippet": "In a recent analysis, Stifel's Martin Landry upgraded BRP Inc. (DOOO, Financial) from a Hold to a Buy, raising the price target from C$45 to C$68. Despite repor...",
"url": "https://www.gurufocus.com/news/2897815/brp-inc-dooo-receives-upgrade-amid-improving-sales-outlook-dooo-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C0000A4NZ.png?20",
"language": "en",
"published_at": "2025-05-30T10:15:31.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "DOOO",
"name": "BRP Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 49.192493,
"sentiment_score": 0.417763,
"highlights": [
{
"highlight": "In a recent analysis, Stifel's Martin La[+317 characters]",
"sentiment": 0.3818,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+275 characters]",
"sentiment": -0.4767,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+310 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+233 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+317 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>BRP</em> <em>Inc</e[+316 characters]",
"sentiment": 0.8807,
"highlighted_in": "main_text"
},
{
"highlight": "<em>BRP</em> <em>Inc</em> (DOOO) reporte[+99 characters]",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "<em>BRP</em> <em>Inc</em>. (DOOO) Receives Upgrade Amid Improving Sales Outlook | DOOO Stock News",
"sentiment": 0.4215,
"highlighted_in": "title"
}
]
},
{
"symbol": "DOO.TO",
"name": "BRP Inc.",
"exchange": null,
"exchange_long": null,
"country": "ca",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 82.51124,
"sentiment_score": 0.433278,
"highlights": [
{
"highlight": "In a recent analysis, Stifel's Martin La[+317 characters]",
"sentiment": 0.3818,
"highlighted_in": "main_text"
},
{
"highlight": "Additionally, concerns about tariffs bei[+128 characters]",
"sentiment": 0.5574,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+275 characters]",
"sentiment": -0.4767,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+319 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+233 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+317 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>BRP</em> <em>Inc</e[+316 characters]",
"sentiment": 0.8807,
"highlighted_in": "main_text"
},
{
"highlight": "<em>BRP</em> <em>Inc</em> (DOOO) reporte[+99 characters]",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "<em>BRP</em> <em>Inc</em>. (DOOO) Receives Upgrade Amid Improving Sales Outlook | DOOO Stock News",
"sentiment": 0.4215,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "33225f1e-3e18-4eef-b9d2-80d665a35898",
"title": "Xylem (XYL) Receives Positive Outlook with Overweight Rating | XYL Stock News",
"description": "JPMorgan analyst Mark Strouse has started coverage on Xylem (XYL), assigning it an Overweight rating with a price target of $148. Xylem stands out as a leader i",
"keywords": "GuruFocus, Article, News, GuruFocus News, XYL",
"snippet": "JPMorgan analyst Mark Strouse has started coverage on Xylem (XYL, Financial), assigning it an Overweight rating with a price target of $148. Xylem stands out as...",
"url": "https://www.gurufocus.com/news/2897812/xylem-xyl-receives-positive-outlook-with-overweight-rating-xyl-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C0000924Q.png?20",
"language": "en",
"published_at": "2025-05-30T10:15:12.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "XYL",
"name": "Xylem Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Industrials",
"match_score": 60.309906,
"sentiment_score": 0.50692,
"highlights": [
{
"highlight": "JPMorgan analyst Mark Strouse has starte[+283 characters]",
"sentiment": 0.0516,
"highlighted_in": "main_text"
},
{
"highlight": "According to the analyst, <em>Xylem</em>[+225 characters]",
"sentiment": 0.7506,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+280 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+328 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+235 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+303 characters]",
"sentiment": 0.6124,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Xylem</em> <em>Inc<[+310 characters]",
"sentiment": 0.891,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Xylem</em> <em>Inc</em> (XYL) reaffi[+295 characters]",
"sentiment": 0.7003,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Xylem</em> <em>Inc</em> (XYL) has ma[+213 characters]",
"sentiment": 0.7351,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Xylem</em> (XYL) Receives Positive Outlook with Overweight Rating | XYL Stock News",
"sentiment": 0.2732,
"highlighted_in": "title"
}
]
},
{
"symbol": "XY6.DE",
"name": "Xylem Inc.",
"exchange": null,
"exchange_long": null,
"country": "de",
"type": "equity",
"industry": "Industrials",
"match_score": 60.287777,
"sentiment_score": 0.50692,
"highlights": [
{
"highlight": "JPMorgan analyst Mark Strouse has starte[+283 characters]",
"sentiment": 0.0516,
"highlighted_in": "main_text"
},
{
"highlight": "According to the analyst, <em>Xylem</em>[+225 characters]",
"sentiment": 0.7506,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+280 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+328 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+235 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+303 characters]",
"sentiment": 0.6124,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Xylem</em> <em>Inc<[+310 characters]",
"sentiment": 0.891,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Xylem</em> <em>Inc</em> (XYL) reaffi[+295 characters]",
"sentiment": 0.7003,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Xylem</em> <em>Inc</em> (XYL) has ma[+213 characters]",
"sentiment": 0.7351,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Xylem</em> (XYL) Receives Positive Outlook with Overweight Rating | XYL Stock News",
"sentiment": 0.2732,
"highlighted_in": "title"
}
]
},
{
"symbol": "XYL.MX",
"name": "Xylem Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Industrials",
"match_score": 60.273193,
"sentiment_score": 0.50692,
"highlights": [
{
"highlight": "JPMorgan analyst Mark Strouse has starte[+283 characters]",
"sentiment": 0.0516,
"highlighted_in": "main_text"
},
{
"highlight": "According to the analyst, <em>Xylem</em>[+225 characters]",
"sentiment": 0.7506,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+280 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+328 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+235 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+303 characters]",
"sentiment": 0.6124,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Xylem</em> <em>Inc<[+310 characters]",
"sentiment": 0.891,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Xylem</em> <em>Inc</em> (XYL) reaffi[+295 characters]",
"sentiment": 0.7003,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Xylem</em> <em>Inc</em> (XYL) has ma[+213 characters]",
"sentiment": 0.7351,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Xylem</em> (XYL) Receives Positive Outlook with Overweight Rating | XYL Stock News",
"sentiment": 0.2732,
"highlighted_in": "title"
}
]
}
]
}
]
},
{
"uuid": "99df6936-d551-4f58-ab72-96684ddacd7f",
"title": "Immuron Letter to Shareholders: Projects Update | IMRN Stock News",
"description": "Immuron (IMRN) projects over A$7 million in sales for the current financial year, a significant rise from last year's A$4.9 million. Topline results of",
"keywords": "GuruFocus, Article, News, GuruFocus News, IMRN",
"snippet": "Immuron (IMRN, Financial) projects over A$7 million in sales for the current financial year, a significant rise from last year's A$4.9 million.\n\nTopline results...",
"url": "https://www.gurufocus.com/news/2897904/immuron-letter-to-shareholders-projects-update-imrn-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C00000L8E.png?20",
"language": "en",
"published_at": "2025-05-30T11:16:23.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "IMRN",
"name": "Immuron Limited",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 70.36575,
"sentiment_score": 0.082867,
"highlights": [
{
"highlight": "<em>Immuron</em> (IMRN, Financial) proje[+311 characters]",
"sentiment": 0.2023,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Immuron</em> <em>Limited</em> (IMRN)[+157 characters]",
"sentiment": 0.2023,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Immuron</em> is preparing to submit [+268 characters]",
"sentiment": 0.0258,
"highlighted_in": "main_text"
},
{
"highlight": "In partnership with Monash University, <[+289 characters]",
"sentiment": 0.34,
"highlighted_in": "main_text"
},
{
"highlight": "As <em>Immuron</em> continues to enhance[+192 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Immuron</em> Letter to Shareholders: Projects Update | IMRN Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "IMRNW",
"name": "Immuron Limited",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "N/A",
"match_score": 70.31647,
"sentiment_score": 0.082867,
"highlights": [
{
"highlight": "<em>Immuron</em> (IMRN, Financial) proje[+311 characters]",
"sentiment": 0.2023,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Immuron</em> <em>Limited</em> (IMRN)[+157 characters]",
"sentiment": 0.2023,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Immuron</em> is preparing to submit [+268 characters]",
"sentiment": 0.0258,
"highlighted_in": "main_text"
},
{
"highlight": "In partnership with Monash University, <[+289 characters]",
"sentiment": 0.34,
"highlighted_in": "main_text"
},
{
"highlight": "As <em>Immuron</em> continues to enhance[+192 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Immuron</em> Letter to Shareholders: Projects Update | IMRN Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "fc5164ad-f402-4073-93a3-25e41e0171f7",
"title": "High Tide Announces Voting Results of Annual General and Special Meeting of Shareholders | HITI Stock News",
"description": "High Tide Inc. (HITI) successfully elected all five director nominees with over 98% approval at its 2025 annual meeting. The company approved fixing the",
"keywords": "GuruFocus, Article, News, GuruFocus News, HITI",
"snippet": "High Tide Inc. (HITI, Financial) successfully elected all five director nominees with over 98% approval at its 2025 annual meeting.\n\nThe company approved fixing...",
"url": "https://www.gurufocus.com/news/2897897/high-tide-announces-voting-results-of-annual-general-and-special-meeting-of-shareholders-hiti-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C0000BJT3.png?20",
"language": "en",
"published_at": "2025-05-30T11:15:50.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "HITI",
"name": "High Tide Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 97.645386,
"sentiment_score": 0.4663,
"highlights": [
{
"highlight": "<em>High</em> <em>Tide</em> <em>Inc</em>[+294 characters]",
"sentiment": 0.9153,
"highlighted_in": "main_text"
},
{
"highlight": "<em>High</em> <em>Tide</em> operates 200[+274 characters]",
"sentiment": 0.4019,
"highlighted_in": "main_text"
},
{
"highlight": "As a major player in the cannabis retail[+295 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Notably, <em>High</em> <em>Tide</em> has[+216 characters]",
"sentiment": 0.6124,
"highlighted_in": "main_text"
},
{
"highlight": "<em>High</em> <em>Tide</em> Announces Voting Results of Annual General and Special Meeting of Shareholders | <em>HITI</em> Stock News",
"sentiment": 0.4019,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "aa2bbb39-e1f8-4acb-a12f-834811a1bf99",
"title": "Qudian Inc. Reports First Quarter 2025 Unaudited Financial Results | QD Stock News",
"description": "Qudian (QD) reports net income of RMB150.1 million ($20.7 million) in Q1 2025, reversing last year's loss. Revenue drops 53.8% to RMB25.8 million ($3.6",
"keywords": "GuruFocus, Article, News, GuruFocus News, QD",
"snippet": "Qudian (QD, Financial) reports net income of RMB150.1 million ($20.7 million) in Q1 2025, reversing last year's loss.\n\nRevenue drops 53.8% to RMB25.8 million ($...",
"url": "https://www.gurufocus.com/news/2897891/qudian-inc-reports-first-quarter-2025-unaudited-financial-results-qd-stock-news",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-05-30T11:15:26.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "QD",
"name": "Qudian Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 96.21811,
"sentiment_score": 0.421875,
"highlights": [
{
"highlight": "<em>Qudian</em> (QD, Financial) reports [+329 characters]",
"sentiment": 0.25,
"highlighted_in": "main_text"
},
{
"highlight": "Despite the decline in revenue, <em>Qudi[+186 characters]",
"sentiment": 0.8126,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Qudian</em> continues its share repu[+311 characters]",
"sentiment": 0.6249,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Qudian</em> <em>Inc</em>. Reports First Quarter 2025 Unaudited Financial Results | QD Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "d160cb06-be88-455e-a073-9487f02b5d7f",
"title": "Immuron Letter to Shareholders: Projects Update",
"description": "Highlights: Immuron on track to exceed A$7 million in Sales this financial yearUniformed Services University anticipates topline results of Travelan®",
"keywords": "GuruFocus, Article, News, Marketwired, IMRN",
"snippet": "Highlights:\n\nImmuron on track to exceed A$7 million in Sales this financial year\n\nUniformed Services University anticipates topline results of Travelan ® clini...",
"url": "https://www.gurufocus.com/news/2897850/immuron-letter-to-shareholders-projects-update",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-05-30T11:00:03.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "IMRN",
"name": "Immuron Limited",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 70.74889,
"sentiment_score": 0.170982,
"highlights": [
{
"highlight": "Highlights:\n\n<em>Immuron</em> on track t[+349 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "IMM-986 (Vancomycin-resistant enterococc[+321 characters]",
"sentiment": 0.7184,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Immuron</em> is on track to exceed A[+119 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "Clinical Trial Update\n\n<em>Immuron</em> [+196 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Following these results <em>Immuron</em>[+300 characters]",
"sentiment": 0.5719,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Immuron</em> has completed a final d[+245 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "ProIBS product launch\n\n<em>Immuron</em> [+135 characters]",
"sentiment": 0.4939,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Immuron</em> has listed ProIBS® in [+332 characters]",
"sentiment": -0.4767,
"highlighted_in": "main_text"
},
{
"highlight": "Pre-clinical Trial Update\n\nOn January 5 [+296 characters]",
"sentiment": -0.3818,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Immuron</em> anticipates the results[+231 characters]",
"sentiment": 0.6369,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Immuron</em> Letter to Shareholders: Projects Update",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "IMRNW",
"name": "Immuron Limited",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "N/A",
"match_score": 70.6908,
"sentiment_score": 0.170982,
"highlights": [
{
"highlight": "Highlights:\n\n<em>Immuron</em> on track t[+349 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "IMM-986 (Vancomycin-resistant enterococc[+321 characters]",
"sentiment": 0.7184,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Immuron</em> is on track to exceed A[+119 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "Clinical Trial Update\n\n<em>Immuron</em> [+196 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Following these results <em>Immuron</em>[+300 characters]",
"sentiment": 0.5719,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Immuron</em> has completed a final d[+245 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "ProIBS product launch\n\n<em>Immuron</em> [+135 characters]",
"sentiment": 0.4939,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Immuron</em> has listed ProIBS® in [+332 characters]",
"sentiment": -0.4767,
"highlighted_in": "main_text"
},
{
"highlight": "Pre-clinical Trial Update\n\nOn January 5 [+296 characters]",
"sentiment": -0.3818,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Immuron</em> anticipates the results[+231 characters]",
"sentiment": 0.6369,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Immuron</em> Letter to Shareholders: Projects Update",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
}
]
},
{
"uuid": "bec1cc07-88b2-43b4-b8e4-4dfda39ef2e3",
"title": "Ivonescimab Plus Chemotherapy Demonstrates Statistically Significant and Clinically Meaningful Improvement in Progression-Free Survival in Patients with EGFR-Mutant Non-Small Cell Lung Cancer after EG",
"description": "Ivonescimab combined with chemotherapy showed a significant improvement in progression-free survival in patients with EGFR-mutant non-small cell lung cance",
"keywords": "GuruFocus, Article, News, GuruFocus News, SMMT",
"snippet": "Ivonescimab combined with chemotherapy showed a significant improvement in progression-free survival in patients with EGFR-mutant non-small cell lung cancer (NS...",
"url": "https://www.gurufocus.com/news/2897901/ivonescimab-plus-chemotherapy-demonstrates-statistically-significant-and-clinically-meaningful-improvement-in-progressionfree-survival-in-patients-with-egfrmutant-nonsmall-cell-lung-cancer-after-eg",
"image_url": "https://static.gurufocus.com/logos/0C00000MNE.png?20",
"language": "en",
"published_at": "2025-05-30T11:16:08.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "SMMT",
"name": "Summit Therapeutics Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 37.788673,
"sentiment_score": 0.5799,
"highlights": [
{
"highlight": "<em>Summit</em> <em>Therapeutics</em> (S[+251 characters]",
"sentiment": 0.4019,
"highlighted_in": "main_text"
},
{
"highlight": "With these findings, <em>Summit</em> <em[+303 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "b9aa8113-8922-42b1-a8be-a0dba7957906",
"title": "Roblox (RBLX) Sees Price Target Boost as User Growth Surges | RBLX Stock News",
"description": "BMO Capital has adjusted its price target for Roblox (RBLX), raising it from $82 to $95, while maintaining an Outperform rating on the stock. This adjustment co",
"keywords": "GuruFocus, Article, News, GuruFocus News, RBLX",
"snippet": "BMO Capital has adjusted its price target for Roblox (RBLX, Financial), raising it from $82 to $95, while maintaining an Outperform rating on the stock. This ad...",
"url": "https://www.gurufocus.com/news/2897898/roblox-rblx-sees-price-target-boost-as-user-growth-surges-rblx-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C0000BZQA.png?20",
"language": "en",
"published_at": "2025-05-30T11:15:55.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "RBLX",
"name": "Roblox Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Communication Services",
"match_score": 75.76867,
"sentiment_score": 0.494613,
"highlights": [
{
"highlight": "BMO Capital has adjusted its price targe[+313 characters]",
"sentiment": 0.4019,
"highlighted_in": "main_text"
},
{
"highlight": "As a result, BMO has increased its Q2 bo[+323 characters]",
"sentiment": 0.0258,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+343 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+238 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+288 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Roblox</em> Corp (<[+258 characters]",
"sentiment": 0.9313,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Roblox</em> Corp (<em>RBLX</em>) is [+118 characters]",
"sentiment": 0.6808,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Roblox</em> (<em>RBLX</em>) Sees Price Target Boost as User Growth Surges | <em>RBLX</em> Stock News",
"sentiment": 0.6486,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "5403a5c5-3f3e-47b0-9957-a6dc54736a25",
"title": "Palomar (PLMR) Sees Increased Price Target and Positive Outlook | PLMR Stock News",
"description": "The financial analyst Meyer Shields from Keefe Bruyette has increased the price target for Palomar (PLMR) to $205, up from $195, while maintaining an Outperform",
"keywords": "GuruFocus, Article, News, GuruFocus News, PLMR",
"snippet": "The financial analyst Meyer Shields from Keefe Bruyette has increased the price target for Palomar (PLMR, Financial) to $205, up from $195, while maintaining an...",
"url": "https://www.gurufocus.com/news/2897877/palomar-plmr-sees-increased-price-target-and-positive-outlook-plmr-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C0000BLPL.png?20",
"language": "en",
"published_at": "2025-05-30T11:00:23.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "PLMR",
"name": "Palomar Holdings, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 58.378418,
"sentiment_score": 0.431457,
"highlights": [
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+299 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+282 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+258 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+303 characters]",
"sentiment": 0.7351,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Palomar</em> <em>Ho[+307 characters]",
"sentiment": 0.7351,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Palomar</em> <em>Holdings</em> <em>I[+292 characters]",
"sentiment": 0.6249,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Palomar</em> <em>Holdings</em> <em>I[+166 characters]",
"sentiment": 0.4404,
"highlighted_in": "main_text"
}
]
}
]
}
]
},
{
"uuid": "a260ed10-e02a-4584-a983-c1d74eec0fef",
"title": "Haemonetics to Present at Goldman Sachs 46th Annual Global Healthcare Conference | HAE Stock News",
"description": "Haemonetics Corporation (HAE) to participate in the Goldman Sachs 46th Annual Global Healthcare Conference. CEO Chris Simon will represent the company i",
"keywords": "GuruFocus, Article, News, GuruFocus News, HAE",
"snippet": "Haemonetics Corporation (HAE, Financial) to participate in the Goldman Sachs 46th Annual Global Healthcare Conference.\n\nCEO Chris Simon will represent the compa...",
"url": "https://www.gurufocus.com/news/2897895/haemonetics-to-present-at-goldman-sachs-46th-annual-global-healthcare-conference-hae-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C00000B6J.png?20",
"language": "en",
"published_at": "2025-05-30T11:15:44.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "HAE",
"name": "Haemonetics Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 60.513344,
"sentiment_score": 0.087467,
"highlights": [
{
"highlight": "<em>Haemonetics</em> <em>Corporation</em[+288 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Haemonetics</em> <em>Corporation</em[+259 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Investors and the general public can con[+272 characters]",
"sentiment": 0.4215,
"highlighted_in": "main_text"
},
{
"highlight": "With a focus on developing hospital tech[+278 characters]",
"sentiment": -0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "This recording will remain accessible on[+151 characters]",
"sentiment": 0.4215,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Haemonetics</em> to Present at Goldman Sachs 46th Annual Global Healthcare Conference | HAE Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "1ef7704b-995c-4ddb-b8bf-ac7c32aaf2a3",
"title": "Quhuo's Homestay Sector Reports YoY Growth in Occupancy Rate During Labor Day Holiday, Continuing to Enhance the Accommodation Experience | QH Stock News",
"description": "Quhuo Limited (QH) reported an 82% occupancy rate for Chengtu Home during the 2025 Labor Day holiday, marking a 4% year-over-year increase. Chengtu Home int",
"keywords": "GuruFocus, Article, News, GuruFocus News, QH",
"snippet": "Quhuo Limited (QH, Financial) reported an 82% occupancy rate for Chengtu Home during the 2025 Labor Day holiday, marking a 4% year-over-year increase.\n\nChengtu ...",
"url": "https://www.gurufocus.com/news/2897893/quhuos-homestay-sector-reports-yoy-growth-in-occupancy-rate-during-labor-day-holiday-continuing-to-enhance-the-accommodation-experience-qh-stock-news",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-05-30T11:15:32.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "QH",
"name": "Quhuo Limited",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 51.141754,
"sentiment_score": 0.584225,
"highlights": [
{
"highlight": "<em>Quhuo</em> <em>Limited</em> (QH, Fin[+237 characters]",
"sentiment": 0.6124,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Quhuo</em> aims to expand its platfo[+283 characters]",
"sentiment": 0.8519,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Quhuo</em> is looking to broaden its[+256 characters]",
"sentiment": 0.5994,
"highlighted_in": "main_text"
},
{
"highlight": "This dual focus on standardization and c[+107 characters]",
"sentiment": 0.2732,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "b426dc7c-0013-4f8f-97c5-31bee2c662df",
"title": "DoubleVerify Holdings Inc (DV) Faces Class Action Lawsuit Over Alleged Securities Fraud | DV stock news",
"description": "Summary DoubleVerify Holdings Inc (DV) is currently embroiled in a class action securities lawsuit, as announced by Levi & Korsinsky, LLP on May 30, 2025. The l",
"keywords": "GuruFocus, Article, News, GuruFocus News, DV",
"snippet": "Summary\n\nDoubleVerify Holdings Inc (DV, Financial) is currently embroiled in a class action securities lawsuit, as announced by Levi & Korsinsky, LLP on May 30,...",
"url": "https://www.gurufocus.com/news/2897885/doubleverify-holdings-inc-dv-faces-class-action-lawsuit-over-alleged-securities-fraud-dv-stock-news",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-05-30T11:02:05.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "DV",
"name": "DoubleVerify Holdings, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Services",
"match_score": 114.161644,
"sentiment_score": -0.396,
"highlights": [
{
"highlight": "Summary\n\n<em>DoubleVerify</em> <em>Holdi[+289 characters]",
"sentiment": -0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "Financial Analyst Perspective\n\nFrom a fi[+325 characters]",
"sentiment": 0.5267,
"highlighted_in": "main_text"
},
{
"highlight": "The lawsuit alleges that <em>DoubleVerif[+311 characters]",
"sentiment": -0.8105,
"highlighted_in": "main_text"
},
{
"highlight": "<em>DoubleVerify</em> <em>Holdings</em> <em>Inc</em> (DV) Faces Class Action Lawsuit Over Alleged Securities Fraud | DV stock news",
"sentiment": -0.5423,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "cf449073-e4a8-4e63-ab2e-bd3cfc6bafcf",
"title": "Shareholders who lost money on DoubleVerify Holdings, Inc. (NYSE: DV) Should Contact Wolf Haldenstein",
"description": "NEW YORK, May 29, 2025 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed against D",
"keywords": "GuruFocus, Article, News, Marketwired, DV",
"snippet": "NEW YORK, May 29, 2025 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed against Dou...",
"url": "https://www.gurufocus.com/news/2897553/shareholders-who-lost-money-on-doubleverify-holdings-inc-nyse-dv-should-contact-wolf-haldenstein",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-05-30T03:00:01.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "DV",
"name": "DoubleVerify Holdings, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Services",
"match_score": 198.37311,
"sentiment_score": 0.0703,
"highlights": [
{
"highlight": "NEW YORK, May 29, 2025 (GLOBE NEWSWIRE) [+173 characters]",
"sentiment": 0.4588,
"highlighted_in": "main_text"
},
{
"highlight": "Shareholders who lost money on <em>DoubleVerify</em> <em>Holdings</em>, <em>Inc</em>. (<em>NYSE</em>: <em>DV</em>) Should Contact Wolf Haldenstein",
"sentiment": -0.3182,
"highlighted_in": "title"
}
]
}
]
}
]
},
{
"uuid": "275f3c2c-3e33-4abb-ad82-7e299bd5fd77",
"title": "Preliminary Q4 2025 Pets at Home Group PLC Earnings Presentation Transcript",
"description": "May 28, 2025 / 08:30AM GMTPresentationMay 28, 2025 / 08:30AM GMT =====================Corporate Participants===================== * Lyssa Mcgowan Pets a",
"keywords": "GuruFocus, Article, News, GuruFocus News, PAHGF",
"snippet": "May 28, 2025 / 08:30AM GMT\n\nPresentation\n\nMay 28, 2025 / 08:30AM GMT\n\n\n\n=====================\n\nCorporate Participants\n\n=====================\n\n* Lyssa Mcgowan\n\nP...",
"url": "https://www.gurufocus.com/news/2897884/preliminary-q4-2025-pets-at-home-group-plc-earnings-presentation-transcript",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-05-30T11:01:33.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "PAHGF",
"name": "Pets at Home Group Plc",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "N/A",
"match_score": 164.67157,
"sentiment_score": 0.1468,
"highlights": [
{
"highlight": "May 28, 2025 / 08:30AM GMT\n\nPresentation[+405 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "=====================\n\n* Jonathan Pritch[+360 characters]",
"sentiment": 0.4404,
"highlighted_in": "main_text"
},
{
"highlight": "Preliminary Q4 2025 <em>Pets</em> <em>at</em> <em>Home</em> <em>Group</em> <em>PLC</em> Earnings Presentation Transcript",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "7a0cc732-498c-4dfa-a26d-65363b51d638",
"title": "Q4 2025 NetApp Inc Earnings Call Transcript",
"description": "May 29, 2025 / 09:30PM GMTOperator Good day, and welcome to the NetApp fourth-quarter and fiscal year 2025 earnings call. (Operator Instructions) Please note th",
"keywords": "GuruFocus, Article, News, GuruFocus News, NTAP",
"snippet": "May 29, 2025 / 09:30PM GMT\n\nOperator\n\n\n\nGood day, and welcome to the NetApp fourth-quarter and fiscal year 2025 earnings call. (Operator Instructions) Please no...",
"url": "https://www.gurufocus.com/news/2897656/q4-2025-netapp-inc-earnings-call-transcript",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-05-30T05:04:27.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "NTAP",
"name": "NetApp, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 95.49748,
"sentiment_score": 0.446833,
"highlights": [
{
"highlight": "May 29, 2025 / 09:30PM GMT\n\nOperator\n\n\n\n[+278 characters]",
"sentiment": 0.9001,
"highlighted_in": "main_text"
},
{
"highlight": "Kris Newton - <em>NetApp</em> <em>Inc</e[+239 characters]",
"sentiment": 0.4404,
"highlighted_in": "main_text"
},
{
"highlight": "Q4 2025 <em>NetApp</em> <em>Inc</em> Earnings Call Transcript",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "NTA.DE",
"name": "NetApp, Inc.",
"exchange": null,
"exchange_long": null,
"country": "de",
"type": "equity",
"industry": "Technology",
"match_score": 95.49389,
"sentiment_score": 0.446833,
"highlights": [
{
"highlight": "May 29, 2025 / 09:30PM GMT\n\nOperator\n\n\n\n[+278 characters]",
"sentiment": 0.9001,
"highlighted_in": "main_text"
},
{
"highlight": "Kris Newton - <em>NetApp</em> <em>Inc</e[+239 characters]",
"sentiment": 0.4404,
"highlighted_in": "main_text"
},
{
"highlight": "Q4 2025 <em>NetApp</em> <em>Inc</em> Earnings Call Transcript",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "0K6F.L",
"name": "NetApp, Inc.",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 95.492584,
"sentiment_score": 0.446833,
"highlights": [
{
"highlight": "May 29, 2025 / 09:30PM GMT\n\nOperator\n\n\n\n[+278 characters]",
"sentiment": 0.9001,
"highlighted_in": "main_text"
},
{
"highlight": "Kris Newton - <em>NetApp</em> <em>Inc</e[+239 characters]",
"sentiment": 0.4404,
"highlighted_in": "main_text"
},
{
"highlight": "Q4 2025 <em>NetApp</em> <em>Inc</em> Earnings Call Transcript",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "N1TA34.SA",
"name": "NetApp, Inc.",
"exchange": null,
"exchange_long": null,
"country": "br",
"type": "equity",
"industry": "Technology",
"match_score": 95.4722,
"sentiment_score": 0.446833,
"highlights": [
{
"highlight": "May 29, 2025 / 09:30PM GMT\n\nOperator\n\n\n\n[+278 characters]",
"sentiment": 0.9001,
"highlighted_in": "main_text"
},
{
"highlight": "Kris Newton - <em>NetApp</em> <em>Inc</e[+239 characters]",
"sentiment": 0.4404,
"highlighted_in": "main_text"
},
{
"highlight": "Q4 2025 <em>NetApp</em> <em>Inc</em> Earnings Call Transcript",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "8d057d2e-a746-4457-aa85-9b4c3813c9e9",
"title": "Q4 2025 Universal Corp Earnings Call Transcript",
"description": "May 29, 2025 / 09:00PM GMTOperator Hello, and thank you for standing by. My name is Tiffany, and I will be your conference operator today. At this time, I would",
"keywords": "GuruFocus, Article, News, GuruFocus News, UVV",
"snippet": "May 29, 2025 / 09:00PM GMT\n\nOperator\n\n\n\nHello, and thank you for standing by. My name is Tiffany, and I will be your conference operator today. At this time, I ...",
"url": "https://www.gurufocus.com/news/2897652/q4-2025-universal-corp-earnings-call-transcript",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-05-30T05:04:22.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "UVV",
"name": "Universal Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Defensive",
"match_score": 13.629793,
"sentiment_score": 0.8689,
"highlights": [
{
"highlight": "At this time, I would like to welcome ev[+229 characters]",
"sentiment": 0.8689,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "0LJD.L",
"name": "Universal Corporation",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 43.98182,
"sentiment_score": 0.526167,
"highlights": [
{
"highlight": "At this time, I would like to welcome ev[+229 characters]",
"sentiment": 0.8689,
"highlighted_in": "main_text"
},
{
"highlight": "Wushuang Ma - <em>Universal</em> Corp - [+192 characters]",
"sentiment": 0.7096,
"highlighted_in": "main_text"
},
{
"highlight": "Q4 2025 <em>Universal</em> Corp Earnings Call Transcript",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "d2d42306-9d93-43a6-9a53-8dddedd0621f",
"title": "Q3 2025 Zscaler Inc Earnings Call Transcript",
"description": "May 29, 2025 / 08:30PM GMTOperator Thank you for standing by and welcome to the Zscaler's third-quarter fiscal year 2025 earnings conference call. At this time,",
"keywords": "GuruFocus, Article, News, GuruFocus News, ZS",
"snippet": "May 29, 2025 / 08:30PM GMT\n\nOperator\n\n\n\nThank you for standing by and welcome to the Zscaler's third-quarter fiscal year 2025 earnings conference call. At this ...",
"url": "https://www.gurufocus.com/news/2897647/q3-2025-zscaler-inc-earnings-call-transcript",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-05-30T05:04:16.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "ZS",
"name": "Zscaler, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 93.0885,
"sentiment_score": 0.3548,
"highlights": [
{
"highlight": "Ashwin Kesireddy - Kesireddy - Vice Pres[+252 characters]",
"sentiment": 0.7096,
"highlighted_in": "main_text"
},
{
"highlight": "Q3 2025 <em>Zscaler</em> <em>Inc</em> Earnings Call Transcript",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "0ZC.DE",
"name": "Zscaler, Inc.",
"exchange": null,
"exchange_long": null,
"country": "de",
"type": "equity",
"industry": "Technology",
"match_score": 93.08331,
"sentiment_score": 0.3548,
"highlights": [
{
"highlight": "Ashwin Kesireddy - Kesireddy - Vice Pres[+252 characters]",
"sentiment": 0.7096,
"highlighted_in": "main_text"
},
{
"highlight": "Q3 2025 <em>Zscaler</em> <em>Inc</em> Earnings Call Transcript",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "ZS.MX",
"name": "Zscaler, Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Technology",
"match_score": 93.07929,
"sentiment_score": 0.3548,
"highlights": [
{
"highlight": "Ashwin Kesireddy - Kesireddy - Vice Pres[+252 characters]",
"sentiment": 0.7096,
"highlighted_in": "main_text"
},
{
"highlight": "Q3 2025 <em>Zscaler</em> <em>Inc</em> Earnings Call Transcript",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "0XVU.L",
"name": "Zscaler, Inc.",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 93.07496,
"sentiment_score": 0.3548,
"highlights": [
{
"highlight": "Ashwin Kesireddy - Kesireddy - Vice Pres[+252 characters]",
"sentiment": 0.7096,
"highlighted_in": "main_text"
},
{
"highlight": "Q3 2025 <em>Zscaler</em> <em>Inc</em> Earnings Call Transcript",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "922569e7-4a07-49eb-9a90-d45ec257a4ac",
"title": "Q2 2025 Nordson Corp Earnings Call Transcript",
"description": "May 29, 2025 / 12:30PM GMTOperator Thank you for standing by, and welcome to the Nordson Corporation second-quarter fiscal year 2025 conference call. (Operator",
"keywords": "GuruFocus, Article, News, GuruFocus News, NDSN",
"snippet": "May 29, 2025 / 12:30PM GMT\n\nOperator\n\n\n\nThank you for standing by, and welcome to the Nordson Corporation second-quarter fiscal year 2025 conference call. (Oper...",
"url": "https://www.gurufocus.com/news/2897619/q2-2025-nordson-corp-earnings-call-transcript",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-05-30T05:03:44.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "NDSN",
"name": "Nordson Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Industrials",
"match_score": 63.947678,
"sentiment_score": 0.410333,
"highlights": [
{
"highlight": "May 29, 2025 / 12:30PM GMT\n\nOperator\n\n\n\n[+226 characters]",
"sentiment": 0.7906,
"highlighted_in": "main_text"
},
{
"highlight": "Lara Mahoney - <em>Nordson</em> Corp - V[+290 characters]",
"sentiment": 0.4404,
"highlighted_in": "main_text"
},
{
"highlight": "Q2 2025 <em>Nordson</em> Corp Earnings Call Transcript",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
}
]
},
{
"uuid": "9a408aca-c411-409f-a211-2bc3413b1768",
"title": "Marvell Technology (MRVL) Faces Price Target Reduction to $90 | MRVL Stock News",
"description": "Wolfe Research has adjusted its price target for Marvell Technology (MRVL), bringing it down to $90 from the previous $115, while maintaining an \"Outperform\" ra",
"keywords": "GuruFocus, Article, News, GuruFocus News, MRVL",
"snippet": "Wolfe Research has adjusted its price target for Marvell Technology (MRVL, Financial), bringing it down to $90 from the previous $115, while maintaining an \"Out...",
"url": "https://www.gurufocus.com/news/2897880/marvell-technology-mrvl-faces-price-target-reduction-to-90-mrvl-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C0000088Q.png?20",
"language": "en",
"published_at": "2025-05-30T11:00:32.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "MRVL",
"name": "Marvell Technology, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 79.89555,
"sentiment_score": 0.431757,
"highlights": [
{
"highlight": "Wolfe Research has adjusted its price ta[+302 characters]",
"sentiment": 0.7506,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+300 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+287 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+257 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+274 characters]",
"sentiment": 0.8316,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Marvell</em> <em>Te[+201 characters]",
"sentiment": 0.8957,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Marvell</em> <em>Technology</em> (MRVL) Faces Price Target Reduction to $90 | MRVL Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "c35af2dd-92e2-4b8f-b084-194e13f653ae",
"title": "Barclays Adjusts Price Target for UiPath (PATH) | PATH Stock News",
"description": "Barclays has revised its price target for UiPath (PATH), increasing it from $12 to $14, while maintaining an Equal Weight rating for the company's shares. The f",
"keywords": "GuruFocus, Article, News, GuruFocus News, PATH",
"snippet": "Barclays has revised its price target for UiPath (PATH, Financial), increasing it from $12 to $14, while maintaining an Equal Weight rating for the company's sh...",
"url": "https://www.gurufocus.com/news/2897842/barclays-adjusts-price-target-for-uipath-path-path-stock-news",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-05-30T10:47:11.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "PATH",
"name": "UiPath Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 92.72054,
"sentiment_score": 0.34362,
"highlights": [
{
"highlight": "Barclays has revised its price target fo[+202 characters]",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "Despite numerous discussions around gove[+227 characters]",
"sentiment": 0.3612,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+288 characters]",
"sentiment": -0.4767,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+344 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+245 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+277 characters]",
"sentiment": 0.5574,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>UiPath</em> <em>Inc[+183 characters]",
"sentiment": 0.8481,
"highlighted_in": "main_text"
},
{
"highlight": "<em>UiPath</em> <em>Inc</em> (<em>PATH</[+325 characters]",
"sentiment": 0.8402,
"highlighted_in": "main_text"
},
{
"highlight": "<em>UiPath</em> <em>Inc</em> (<em>PATH</[+198 characters]",
"sentiment": -0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "Barclays Adjusts Price Target for <em>UiPath</em> (<em>PATH</em>) | <em>PATH</em> Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "baef968c-6f46-497a-8f40-6548d416af9f",
"title": "Barclays Analyst Adjusts Price Target for GAP (GAP) Stock | GAP Stock News",
"description": "Barclays analyst Adrienne Yih has revised the price target for Gap (GAP), adjusting it down to $32 from the previous $33, while maintaining an Overweight rating",
"keywords": "GuruFocus, Article, News, GuruFocus News, GAP",
"snippet": "Barclays analyst Adrienne Yih has revised the price target for Gap (GAP, Financial), adjusting it down to $32 from the previous $33, while maintaining an Overwe...",
"url": "https://www.gurufocus.com/news/2897841/barclays-analyst-adjusts-price-target-for-gap-gap-stock-gap-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C000007SZ.png?20",
"language": "en",
"published_at": "2025-05-30T10:47:04.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "GAP.DE",
"name": "The Gap, Inc.",
"exchange": null,
"exchange_long": null,
"country": "de",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 21.486418,
"sentiment_score": 0.50225,
"highlights": [
{
"highlight": "More detailed estimate data can be found[+318 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on <em>t[+330 characters]",
"sentiment": 0.4939,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "GPS",
"name": "The Gap, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 13.063535,
"sentiment_score": 0.50225,
"highlights": [
{
"highlight": "More detailed estimate data can be found[+318 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on <em>t[+330 characters]",
"sentiment": 0.4939,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "GPS.MX",
"name": "The Gap, Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 21.48624,
"sentiment_score": 0.50225,
"highlights": [
{
"highlight": "More detailed estimate data can be found[+318 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on <em>t[+330 characters]",
"sentiment": 0.4939,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "0ITS.L",
"name": "The Gap, Inc.",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 21.486235,
"sentiment_score": 0.50225,
"highlights": [
{
"highlight": "More detailed estimate data can be found[+318 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on <em>t[+330 characters]",
"sentiment": 0.4939,
"highlighted_in": "main_text"
}
]
}
]
}
]
},
{
"uuid": "b86f4c86-edce-43c1-b6aa-0721c28d5855",
"title": "Zscaler (ZS) Price Target Raised Amid Strong Q3 Results | ZS Stock News",
"description": "Citizens JMP has elevated its price target for Zscaler (ZS) from $240 to $310, maintaining an Outperform rating on the stock. This decision follows Zscaler's im",
"keywords": "GuruFocus, Article, News, GuruFocus News, ZS",
"snippet": "Citizens JMP has elevated its price target for Zscaler (ZS, Financial) from $240 to $310, maintaining an Outperform rating on the stock. This decision follows Z...",
"url": "https://www.gurufocus.com/news/2897876/zscaler-zs-price-target-raised-amid-strong-q3-results-zs-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C0000BEGL.png?20",
"language": "en",
"published_at": "2025-05-30T11:00:14.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "ZS",
"name": "Zscaler, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 54.980656,
"sentiment_score": 0.4939,
"highlights": [
{
"highlight": "Citizens JMP has elevated its price targ[+246 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+282 characters]",
"sentiment": -0.4767,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+330 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+237 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+230 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Zscaler</em> <em>In[+255 characters]",
"sentiment": 0.9287,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Zscaler</em> <em>Inc</em> (ZS) maint[+310 characters]",
"sentiment": 0.872,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Zscaler</em> <em>Inc</em> (ZS) conti[+197 characters]",
"sentiment": 0.7717,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Zscaler</em> (ZS) Price Target Raised Amid Strong Q3 Results | ZS Stock News",
"sentiment": 0.5106,
"highlighted_in": "title"
}
]
}
],
"similar": []
}
]
}
Sentiment
Live response for past 24 hours
{
"meta": {
"returned": 1,
"limit": 10
},
"data": [
{
"key": "us",
"total_documents": 3778,
"sentiment_avg": 0.2942379464391165
}
]
}
Other details
Entity count
- 32,649